These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 26613760)
1. Serum Cystatin C as an Inflammatory Marker in Exacerbated and Convalescent COPD Patients. Zhang M; Li Y; Yang X; Shan H; Zhang Q; Ming Z; Xie Y; Chen H; Liu Y; Zhang J Inflammation; 2016 Apr; 39(2):625-31. PubMed ID: 26613760 [TBL] [Abstract][Full Text] [Related]
2. The clinical implication of serum cyclophilin A in patients with chronic obstructive pulmonary disease. Zhang M; Tang J; Yin J; Wang X; Feng X; Yang X; Shan H; Zhang Q; Zhang J; Li Y Int J Chron Obstruct Pulmon Dis; 2018; 13():357-363. PubMed ID: 29403273 [TBL] [Abstract][Full Text] [Related]
3. Mean platelet volume is elevated in exacerbated and convalescent COPD patients. Zhang M; Li Y; Zhang J; Zhang Q; Yang X; Shan H; Xie Y; Jin Q; Feng X Clin Chim Acta; 2015 Dec; 451(Pt B):227-31. PubMed ID: 26436484 [TBL] [Abstract][Full Text] [Related]
4. D-dimer as a potential biomarker for the progression of COPD. Zhang M; Zhang J; Zhang Q; Yang X; Shan H; Ming Z; Chen H; Liu Y; Yin J; Li Y Clin Chim Acta; 2016 Apr; 455():55-9. PubMed ID: 26826394 [TBL] [Abstract][Full Text] [Related]
5. The association between cystatin C and COPD: a meta-analysis and systematic review. Chai L; Feng W; Zhai C; Shi W; Wang J; Yan X; Wang Q; Zhang Q; Li M BMC Pulm Med; 2020 Jun; 20(1):182. PubMed ID: 32586317 [TBL] [Abstract][Full Text] [Related]
6. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease. Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627 [TBL] [Abstract][Full Text] [Related]
7. The Ratio Serum Creatinine/Serum Cystatin C (a Surrogate Marker of Muscle Mass) as a Predictor of Hospitalization in Chronic Obstructive Pulmonary Disease Outpatients. Amado CA; García-Unzueta MT; Lavin BA; Guerra AR; Agüero J; Ramos L; Muñoz P Respiration; 2019; 97(4):302-309. PubMed ID: 30481791 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of neutrophil to lymphocyte ratio in patients with chronic obstructive pulmonary disease: a prospective observational study. Lee SJ; Lee HR; Lee TW; Ju S; Lim S; Go SI; You JW; Cho YJ; Lee GW; Jeong YY; Kim HC; Lee JD Korean J Intern Med; 2016 Sep; 31(5):891-8. PubMed ID: 27017385 [TBL] [Abstract][Full Text] [Related]
9. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease. Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413 [TBL] [Abstract][Full Text] [Related]
10. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083 [TBL] [Abstract][Full Text] [Related]
11. Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease. Wang RT; Li JY; Cao ZG; Li Y Respirology; 2013 Nov; 18(8):1244-8. PubMed ID: 23786593 [TBL] [Abstract][Full Text] [Related]
12. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD. Karadag F; Karul AB; Cildag O; Yilmaz M; Ozcan H Lung; 2008; 186(6):403-9. PubMed ID: 18807087 [TBL] [Abstract][Full Text] [Related]
14. Association of Serum Galectin-3 with the Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Feng W; Wu X; Li S; Zhai C; Wang J; Shi W; Li M Med Sci Monit; 2017 Sep; 23():4612-4618. PubMed ID: 28947730 [TBL] [Abstract][Full Text] [Related]
15. Plasma Cathepsin S and Cathepsin S/Cystatin C Ratios Are Potential Biomarkers for COPD. Nakajima T; Nakamura H; Owen CA; Yoshida S; Tsuduki K; Chubachi S; Shirahata T; Mashimo S; Nakamura M; Takahashi S; Minematsu N; Tateno H; Fujishima S; Asano K; Celli BR; Betsuyaku T Dis Markers; 2016; 2016():4093870. PubMed ID: 27994288 [No Abstract] [Full Text] [Related]
16. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease. Hirai K; Tanaka A; Homma T; Goto Y; Akimoto K; Uno T; Yoshitaka U; Miyata Y; Inoue H; Ohta S; Suzuki S; Sagara H Clin Nutr; 2021 Mar; 40(3):1274-1280. PubMed ID: 32863062 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels. Yoshizawa T; Okada K; Furuichi S; Ishiguro T; Yoshizawa A; Akahoshi T; Gon Y; Akashiba T; Hosokawa Y; Hashimoto S Int J Chron Obstruct Pulmon Dis; 2015; 10():1283-9. PubMed ID: 26185434 [TBL] [Abstract][Full Text] [Related]
18. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease]. Long H; Luo H; Chen P; Li Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727 [TBL] [Abstract][Full Text] [Related]
19. Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients. Wu Y; Shen Y; Zhang J; Wan C; Wang T; Xu D; Yang T; Wen F Int J Chron Obstruct Pulmon Dis; 2015; 10():2405-12. PubMed ID: 26609227 [TBL] [Abstract][Full Text] [Related]
20. The Role of Mean Platelet Volume in Chronic Obstructive Pulmonary Disease Exacerbation. Agapakis DI; Massa EV; Hantzis I; Maraslis S; Alexiou E; Imprialos KP; Damianidou M; Satsoglou E Respir Care; 2016 Jan; 61(1):44-9. PubMed ID: 26604328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]